Accessibility Menu
Oncorus logo

Oncorus(NASDAQ) ONCR

This security has been delisted. This page is retained for historical reference.

Oncorus last closing stock price
MetricPriceDate
Last closeUSD 0.132023-12-29
Oncorus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+869.23%USD 0.012023-12-22
1 month+500%USD 0.022023-11-29
3 month+344.05%USD 0.032023-09-29
Year to date-50.26%USD 0.252022-12-30
1 year-50.63%USD 0.262022-12-29
3 year-99.63%USD 33.902020-12-29
Since inception-99.21%USD 16.002020-10-02

ONCR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

ONCR Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-82.19%

Return on Capital

-59.36%

Return on Assets

-53.79%

Earnings Yield

N/A

Dividend Yield

110.58%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$88.42M

EBITDA

-$100.97M

Operating Cash Flow

-$55.70M

Capital Expenditure

-$18.14M

Free Cash Flow

-$73.84M

Cash & ST Invst.

$44.98M

Total Debt

$69.25M

Oncorus Performance Analysis

Oncorus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 0N/A
20222022-12-31USD 0N/A
Oncorus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-30N/A
Q32022-09-30N/A
Q42022-12-31N/A
Q12023-03-31N/A
Oncorus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -2.56N/A
20222022-12-31USD -2.9916.8%
Oncorus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22022-06-30-8.7%
Q32022-09-30-2.7%
Q42022-12-31-7.8%
Q12023-03-31-54.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

64

N/A

Net Income

-$33.29M

-87.6%

EBITDA

-$44.38M

-159.2%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$44.98M

-54.4%

Total Debt

$69.25M

+34.2%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$47.52M

-4.8%

Short Term Debt

$21.73M

+1194.7%

Return on Assets

-53.79%

N/A

Return on Invested Capital

-70.62%

N/A

Free Cash Flow

-$17.52M

+30.8%

Operating Cash Flow

-$17.45M

+25.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDRAIdera Pharmaceuticals, Inc.
$0.43-23.04%
QTTBQ32 Bio Inc.
$15.82+4.35%
ARAVAravive, Inc.
$0.04-13.39%
ONCOOnconetix, Inc.
$0.83+1.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.89+0.30%
AMIXAutonomix Medical
$17.70+3.85%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.06+0.03%
NOKNokia
$10.05+0.07%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.